1BHT | A:35-126; B:336-426 | NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR |
1GMN | A:38-125; B:42-125 | CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR |
1GMO | A:37-125; B:37-125; C:37-125; D:37-125; E:37-125; F:37-125; G:38-125; H:38-125 | CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR |
1GP9 | A:39-125; B:39-125; C:38-125; D:39-125 | A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING |
1NK1 | A:38-125; B:38-125 | NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION |
2HGF | A: | HAIRPIN LOOP CONTAINING DOMAIN OF HEPATOCYTE GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE |
2QJ2 | A:36-126; B:1035-1126 | A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST |
3HMS | A: | CRYSTAL CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (28-126) OF THE HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR, ORTHORHOMBIC CRYSTAL FORM |
3HMT | A:; B: | CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (28-126) OF THE HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR, TRIGONAL CRYSTAL FORM |
3HN4 | A:34-126 | CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (28-289) OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR |
3SP8 | A:35-126; B:34-126 | CRYSTAL STRUCTURE OF NK2 IN COMPLEX WITH FRACTIONATED HEPARIN DP10 |